Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2026-01-04 @ 8:51 PM
Study NCT ID:
NCT05272150
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2022-03-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-01
First Submit QC Date:
None
Study First Post Date:
2022-03-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-09-12
Last Update Post Date Type:
ESTIMATED